Melatonin decreases the viability of BeWo cells under hypoxia/reoxygenation. by Lucas Sagrillo-Fagundes (6194843)

Decreased FA number in Rgnef−/− MEFs on fibronectin (FN) at 90 min. by Nichol L. G. Miller (162752)

“…Cells were fixed and analyzed for FA formation by paxillin staining (green), f-actin (phalloidin, red), and nuclei were stained with Hoechst (blue) as shown in a merged image. Scale is 10 µm. Significantly-reduced adhesion number (B) and decreased median adhesion size (C) in Rgnef−/− compared to normal (Rgnef+/+) MEFs. …”

Down-regulation of Gli decreased ovarian cancer cell migration and invasion. by Qi Chen (144168)

“…ES2 and SKOV3 cells were treated with control vehicle (DMSO) or GANT61 (20 µM) for 48 hr. Subsequently, cells were stained with Gli2 and visualized under a confocal microscope. …”

Downregulation of SPHK1 expression decreases the resistance of glioma cells to apoptosis. by Hongyu Guan (351333)

“…(B) Silencing of SPHK1 led to significant decrease of enzymatic activity in glioma cells. (C) Knockdown of SPHK1 enhances cell death. …”

MET knockdown decreases EGFR activation and does not influence EGFR expression. by Karolin Ebert (7434713)

Pregnancy is associated with decreased polyubiquitinated protein levels, but not de-ubiqutination levels. by Andrea Iorga (298552)

RSV decreases the inflammatory status in high fat-fed diabetic mice. by Thi-Mai Anh Dao (350268)

Chronic RAS blockade decreases AT₁R expression. by Lai Ming Yung (353970)

Decreased vagal activity and deviation in sympathetic activity precedes development of diabetes by Da Young Lee (8617365)

Ammonium decreases apparent root meristem size and the number of dividing cells. by Ying Liu (18461)

Probability of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

QA treatment decreases the expression of PP1, PP2 and PP5 but increases the expression of PP2B: by Abdur Rahman (261729)

Search duration decreases with target value and increases with the environment’s probability of containing a reward target. by Michael R. Traner (11836571)

DG treatment decreased the oxidative stress induced by Aβ_1–42. by Xiaolei Zhu (325492)

HDACi exposure in DHA-treated cells enhanced decreases of Mcl-1 and p-ERK. A. by Chris Zhiyi Zhang (111721)

Tunicamycin produces a concentration- and time-dependent decrease in cell viability in SH-SY5Y cells concomitant with caspase-3 activation. by Arindam P. Ghosh (317870)

“…<p>(A) Treatment of SH-SY5Y cells with tunicamycin (0.1–5µM) for 24 h caused a progressive decrease in cell viability as measured by Calcein AM cleavage assay. …”

Introduction of the F region decreases the amount of extracellular PSMs and increases the amount of extracellular FnbA. by Chikara Kaito (230958)

Expression of <i>lcat</i>, but not <i>cetp</i>, is significantly decreased in <i>apoc2</i> mutant zebrafish. by Chao Liu (1234536)

A blue-shifted fluorescence donor increases fAP amplitude but exhibits a decreased SNR. A. by Ann E. Fink (312543)

OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

“…However, co-treatment of OCA with Gemcitabine or Cisplatin resulted in a tumor volume significantly lower compared to Gemcitabine or Cisplatin alone (p < 0.05). Means ± SE of N = 5 for each group. * p < 0.05 vs controls, ^& p < 0.05 vs OCA, ^¤ p < 0.05 vs Cisplatin alone, ^§ p < 0.05 vs Gemcitabine alone. …”